Anti-Human ECSIT (CT)

Anti-Human ECSIT (CT)

Product No.: E184

[product_table name="All Top" skus="E184"]

- -
- -
Target
ECSIT
Product Type
Polyclonal Antibody
Alternate Names
Evolutionarily Conserved Signaling Intermediate in Toll Pathway
Applications
IHC FFPE
,
WB

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Human
Host Species
Rabbit
Immunogen
PN:E185
Product Concentration
0.5 mg/ml
Formulation
This polyclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.4 containing 0.02% sodium azide as a preservative.
Storage and Handling
This polyclonal antibody is stable for at least one week when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at –20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Description

Specificity
Rabbit Anti-Human ECSIT recognizes an epitope near the C-terminus of Human and Mouse ECSIT. This polyclonal antibody was purified using affinity chromatography.
Background
Activation of NF-?B as a result of Toll-like receptor (TLR) and IL-1 receptor signaling is a major component of innate immune responses (reviewed in 1). Signals from these receptors are relayed by a number of adapter molecules such as TRIF, TIRAP, and MyD88 (2) to kinases such as IRAK (3) and other intermediates such as TNF receptor associated factor (TRAF)-6 (4). ECSIT (evolutionarily conserved signaling intermediate in Toll pathways) was initially identified as a cytoplasmic protein interacting specifically with TNF receptor associated factor (TRAF)-6 in the TLR pathway (5). Recently however, ECSIT has also been shown to be required for bone morphogenetic protein (Bmp) signaling and mesoderm formation during mouse embryogenesis (6), indicating the possibility of cross-talk between the TLR/IL-B and Bmp signaling pathways.
PubMed

References & Citations

1. Takeda, K. et al. (2003) Annu. Rev. Immunol. 21:335
2. Vogel, SN. et al. (2003) Mol. Interv. 3:466
3. Janssens, S. et al. (2003) Mol. Cell. 11:293
4. Sato, S. et al. (2003) J. Immunol. 171(8):4304
IHC FFPE
General Western Blot Protocol

Certificate of Analysis

- -
- -
Prod No.
Description
E184
E185
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.